Hologic expands Acclaim DEXA series
Bone densitometry firm Hologic will showcase the expansion ofits QDR-4500 Acclaim line of dual-energy x-ray absorptiometryscanners, which debuted at last year's RSNA meeting with the introductionof the QDR-4500A system. Hologic, of Waltham, MA, has added
Bone densitometry firm Hologic will showcase the expansion ofits QDR-4500 Acclaim line of dual-energy x-ray absorptiometryscanners, which debuted at last year's RSNA meeting with the introductionof the QDR-4500A system.
Hologic, of Waltham, MA, has added three new DEXA scanners tothe line, to be positioned at price points below the flagshipQDR-4500A. QDR-4500C is for spine and hip scanning, QDR-4500Wis targeted at spine, hip and total body work, and QDR-4500SLis for spine, hip and lateral scanning, according to Joel Weinstein,vice president of business development and marketing. Any of thenew scanners can be upgraded to the QDR-4500A.
Hologic will also show a new ultrasound bone densitometry productcalled Sahara. Sahara is based on technology Hologic acquiredwhen it bought WalkerSonix earlier this year. Sahara differs fromthe WalkerSonix devices and other ultrasound densitometers onthe market in that it does not require a water bath for bone scanning,Weinstein said.
Hologic this month reported strong financial results for its1995 fiscal year due to increased interest in bone densitometry.The company saw revenues increase 13% to $43.4 million while netincome stood at $1.9 million, a drop of 38% caused by legal costsassociated with its patent litigation with Lunar. The financialresults prompted the company's stock to surge 13% on Nov. 8 to$29.75 a share.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
